Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash & Current Investments (2016 - 2025)

Bio-Techne has reported Cash & Current Investments over the past 17 years, most recently at $172.9 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $172.9 million for Q4 2025, down 4.37% from a year ago — trailing twelve months through Dec 2025 was $172.9 million (down 4.37% YoY), and the annual figure for FY2025 was $165.0 million, up 7.96%.
  • Cash & Current Investments for Q4 2025 was $172.9 million at Bio-Techne, up from $145.0 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for TECH hit a ceiling of $279.0 million in Q4 2021 and a floor of $135.7 million in Q4 2023.
  • Median Cash & Current Investments over the past 5 years was $182.2 million (2022), compared with a mean of $189.8 million.
  • Biggest five-year swings in Cash & Current Investments: tumbled 32.0% in 2023 and later surged 33.26% in 2024.
  • Bio-Techne's Cash & Current Investments stood at $279.0 million in 2021, then dropped by 29.47% to $196.8 million in 2022, then tumbled by 31.06% to $135.7 million in 2023, then surged by 33.26% to $180.8 million in 2024, then decreased by 4.37% to $172.9 million in 2025.
  • The last three reported values for Cash & Current Investments were $172.9 million (Q4 2025), $145.0 million (Q3 2025), and $165.0 million (Q2 2025) per Business Quant data.